Avanos Medical (AVNS) Work In Process (2014 - 2026)

Avanos Medical (AVNS) has 13 years of Work In Process data on file, last reported at $25.0 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 10.13% year-over-year to $25.0 million; the trailing twelve-month figure through Mar 2026 stood at $25.0 million (up 10.13% YoY), and the FY2025 full-year result was $25.2 million, up 19.43% from the prior year.
• Work In Process slipped to $25.0 million in Q1 2026, from $25.2 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $34.7 million in Q2 2022 to a low of $19.8 million in Q4 2023.
• A 5-year average of $26.5 million and a median of $25.0 million in 2026 frame the typical range for Work In Process.
• Across the five-year window, Work In Process slumped 31.7% in 2023 and grew 26.29% in 2025, its largest moves.
• Tracing AVNS's Work In Process over 5 years: stood at $23.8 million in 2022, then declined by 16.81% to $19.8 million in 2023, then increased by 6.57% to $21.1 million in 2024, then increased by 19.43% to $25.2 million in 2025, then fell by 0.79% to $25.0 million in 2026.
• Business Quant data shows AVNS's Work In Process at $25.0 million in Q1 2026, $25.2 million in Q4 2025, and $29.3 million in Q3 2025.